SightfileU.S. market data from official filings

Companies › INDP

Indaptus Therapeutics Inc (INDP)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001857044 · EDGAR filings · Updated 2026-07-17

Indaptus Therapeutics Inc (INDP) has reported institutional ownership of 3.1%, with 6 institutional managers holding positions valued at $128.5K per the latest 13F reporting period. SEC filings include an active material impairment disclosure (8-K Item 2.06), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
3.1%
Institutional managers
6
Reported 13F value
$128.5K
Insider activity
6 trans.
$0 net flat
Data flags
3 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Indaptus Therapeutics Inc has 6 institutional holders and institutional ownership of 3.1%.

Insider activity

Insiders reported 6 transactions (0 buys, 0 sells) across 8 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-15 (recurring since 2021-06-28) — source filing. The authoritative details are those stated in the filing itself.
Active material impairment disclosure (8-K Item 2.06), most recently filed 2021-08-16 (recurring since 2021-08-06) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2021-08-06 (recurring since 2021-08-06) — source filing. The authoritative details are those stated in the filing itself.

Related companies

VivoSim Labs Inc (VIVS) · CHINA SXT PHARMACEUTICALS IN (SXTC) · Dermata Therapeutics Inc (DRMA) · Sunshine Biopharma Inc (SBFM) · AZITRA INC (AZTR) · ZOMEDICA CORP COM (ZOMDF)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-17.